Exchange: NASDAQ·Updated 07:00 AM EDT
GALT logo

GALT Galectin Therapeutics Inc

$4.02
$0.46
(10.27%)
Pre-Market
Prev Close $4.48
Reported EarningsAug 14
Mkt Cap$420.54M
Vol54.00

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
56

Bullish Sentiment

How do you feel about GALT?

Advertisement|Remove ads.